MEIP Projected Dividend Yield
Com Par$/MEI Pharma Inc ( NASDAQ : MEIP )MEI Pharma is a clinical-stage pharmaceutical company focused on developing cancer therapies. Co.'s drug candidate pipeline includes voruciclib, an oral cyclin-dependent kinase 9 inhibitor, and ME-344, an intravenous small molecule mitochondrial inhibitor targeting the oxidative phosphorylation pathway. 11 YEAR PERFORMANCE RESULTS |
MEIP Dividend History Detail MEIP Dividend News MEIP Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2023 |
Nov 06, 2023 |
Nov 16, 2023 |
Nov 17, 2023 |
Dec 06, 2023 |
1.7500 |
2023 Total: |
1.7500 |